Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...
Axios Boston on MSN4h
Mass. files suit accusing insulin makers of price-gougingMassachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback